
Prostate cancer poses a significant health threat in Sub-Saharan Africa (SSA), marked by high incidence and mortality rates. Unfortunately, the widely used prostate-specific antigen (PSA) screening is often unavailable/unaffordable in the region. As a solution, alternative screening methods like risk stratification and cost-effective PSA tests are being explored to target high-risk individuals and increase accessibility. However, SSA faces diagnostic challenges due to limited access to tools and healthcare resources, leading to late-stage diagnoses. Treatment options are also constrained by resource scarcity and cultural stigmas. Enhancing awareness, electronic records, and genetics understanding may aid in controlling SSA's prostate cancer burden.
Like
Save
Share